Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.

about

Annona glabra Flavonoids Act As Antimicrobials by Binding to Pseudomonas aeruginosa Cell Walls Investigational α-synuclein aggregation inhibitors: hope for Parkinson's disease.FLZ Attenuates α-Synuclein-Induced Neurotoxicity by Activating Heat Shock Protein 70.

P2860

Q28816955-9FE0E64D-6487-486D-BC57-E3FAED0B1720 Q38817063-36629A7D-379A-4EF9-B83F-030A923BA446 Q49029474-0D9DC1C3-5535-477C-97AC-D7506ADA8D54

P2860

Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.

Item

http://www.wikidata.org/entity/Q53618094

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Squamosamide derivative FLZ pr ...... model of Parkinson's disease.

@en

Squamosamide derivative FLZ pr ...... model of Parkinson's disease.

@nl

type

Item

label

Squamosamide derivative FLZ pr ...... model of Parkinson's disease.

@en

Squamosamide derivative FLZ pr ...... model of Parkinson's disease.

@nl

prefLabel

Squamosamide derivative FLZ pr ...... model of Parkinson's disease.

@en

Squamosamide derivative FLZ pr ...... model of Parkinson's disease.

@nl

P1476

Squamosamide derivative FLZ pr ...... model of Parkinson's disease.

@en

P2093

Dan Zhang

http://www.w3.org/2001/XMLSchema#string

Hua Sun

http://www.w3.org/2001/XMLSchema#string

Liang-Yu Wu

http://www.w3.org/2001/XMLSchema#string

Xiao-Liang Wang

http://www.w3.org/2001/XMLSchema#string

Xiu-Qi Bao

http://www.w3.org/2001/XMLSchema#string

P2860

Tyrosine hydroxylase and Parkinson's disease

Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of alpha-synuclein.

Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo.

Role of alpha-synuclein protein levels in mitochondrial morphology and cell survival in cell lines.

Silencing alpha-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells.

The Akt-GSK-3 signaling cascade in the actions of dopamine.

Presynaptic alpha-synuclein aggregation in a mouse model of Parkinson's disease.

Mammalian target of rapamycin: discovery of rapamycin reveals a signaling pathway important for normal and cancer cell growth.

Role of mammalian target of rapamycin in hypoxic or ischemic brain injury: potential neuroprotection and limitations.

Parkinson's disease: from genetics to treatments.

P2888

s00210-015-1094-5

P304

549-556

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00210-015-1094-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

388

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25678053

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.

about

P2860

P2860

Squamosamide derivative FLZ protected tyrosine hydroxylase function in a chronic MPTP/probenecid mouse model of Parkinson's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921